Ignite Creation Date:
2024-05-06 @ 5:56 PM
Last Modification Date:
2024-10-26 @ 2:38 PM
Study NCT ID:
NCT05482087
Status:
NOT_YET_RECRUITING
Last Update Posted:
2022-08-01
First Post:
2022-07-21
Brief Title:
A Study of XZP-3621 in Chinese Patients With ALK Positive NSCLC
Sponsor:
Xuanzhu Biopharmaceutical Co Ltd
Organization:
Xuanzhu Biopharmaceutical Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-09
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-05-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-07-01
Completion Date Type:
ESTIMATED
First Submit Date:
2022-07-21
First Submit QC Date:
July 29 2022
Study First Post Date:
2022-08-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-07-29
Last Update Post Date:
2022-08-01
Last Update Post Date Type:
ACTUAL